185 related articles for article (PubMed ID: 34678593)
1. Protective effects of spironolactone on vascular calcification in chronic kidney disease.
Hammer F; Buehling SS; Masyout J; Malzahn U; Hauser T; Auer T; Grebe S; Feger M; Tuffaha R; Degenhart G; Lang F; Pasch A; Alesutan I; Wanner C; Krane V; Voelkl J
Biochem Biophys Res Commun; 2021 Dec; 582():28-34. PubMed ID: 34678593
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
3. Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.
Alesutan I; Voelkl J; Feger M; Kratschmar DV; Castor T; Mia S; Sacherer M; Viereck R; Borst O; Leibrock C; Gawaz M; Kuro-O M; Pilz S; Tomaschitz A; Odermatt A; Pieske B; Wagner CA; Lang F
Sci Rep; 2017 May; 7(1):2059. PubMed ID: 28515448
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
Choi SY; Ryu HM; Oh EJ; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
PLoS One; 2017; 12(7):e0180393. PubMed ID: 28686724
[TBL] [Abstract][Full Text] [Related]
5. Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice.
Voelkl J; Alesutan I; Leibrock CB; Quintanilla-Martinez L; Kuhn V; Feger M; Mia S; Ahmed MS; Rosenblatt KP; Kuro-O M; Lang F
J Clin Invest; 2013 Feb; 123(2):812-22. PubMed ID: 23298834
[TBL] [Abstract][Full Text] [Related]
6. p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.
Li KL; Chen J; Li ZH; Zhao L; He YN
Cardiovasc J Afr; 2012 Jul; 23(6):e1-9. PubMed ID: 22143460
[TBL] [Abstract][Full Text] [Related]
7. Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling.
Alesutan I; Luong TTD; Schelski N; Masyout J; Hille S; Schneider MP; Graham D; Zickler D; Verheyen N; Estepa M; Pasch A; Maerz W; Tomaschitz A; Pilz S; Frey N; Lang F; Delles C; Müller OJ; Pieske B; Eckardt KU; Scherberich J; Voelkl J
Cardiovasc Res; 2021 Feb; 117(3):930-941. PubMed ID: 32243494
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of osteo/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor.
Alesutan I; Tuffaha R; Auer T; Feger M; Pieske B; Lang F; Voelkl J
J Hypertens; 2017 Mar; 35(3):523-532. PubMed ID: 27984337
[TBL] [Abstract][Full Text] [Related]
9. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1.
Wang P; Quan Z; Luo D; Chen W; Peng D
Mol Med Rep; 2019 May; 19(5):3622-3632. PubMed ID: 30896801
[TBL] [Abstract][Full Text] [Related]
11. Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
Zhai X; Cao S; Wang J; Qiao B; Liu X; Hua R; Zhao M; Sun S; Han Y; Wu S; Pang J; Yuan Q; Wang B; Xu F; Wei S; Chen Y
Circulation; 2024 May; 149(22):1752-1769. PubMed ID: 38348663
[TBL] [Abstract][Full Text] [Related]
12. Vascular calcification--is aldosterone a culprit?
Lang F; Ritz E; Voelkl J; Alesutan I
Nephrol Dial Transplant; 2013 May; 28(5):1080-4. PubMed ID: 23476041
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34b/c inhibits aldosterone-induced vascular smooth muscle cell calcification via a SATB2/Runx2 pathway.
Hao J; Zhang L; Cong G; Ren L; Hao L
Cell Tissue Res; 2016 Dec; 366(3):733-746. PubMed ID: 27503378
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of phosphate-induced osteo-/chondrogenic transformation of vascular smooth muscle cells by homoarginine.
Alesutan I; Feger M; Tuffaha R; Castor T; Musculus K; Buehling SS; Heine CL; Kuro-O M; Pieske B; Schmidt K; Tomaschitz A; Maerz W; Pilz S; Meinitzer A; Voelkl J; Lang F
Cardiovasc Res; 2016 Jun; 110(3):408-18. PubMed ID: 27001421
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling.
Xiao Q; Tang Y; Luo H; Chen S; Chen R; Yan Z; Pu L; Wang L; Li G; Li Y
Ren Fail; 2022 Dec; 44(1):1426-1442. PubMed ID: 36017689
[TBL] [Abstract][Full Text] [Related]
17. Endogenous aldosterone is involved in vascular calcification in rat.
Wu SY; Yu YR; Cai Y; Jia LX; Wang X; Xiao CS; Tang CS; Qi YF
Exp Biol Med (Maywood); 2012 Jan; 237(1):31-7. PubMed ID: 22185918
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
19. Impact of C-reactive protein on osteo-/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells.
Henze LA; Luong TTD; Boehme B; Masyout J; Schneider MP; Brachs S; Lang F; Pieske B; Pasch A; Eckardt KU; Voelkl J; Alesutan I
Aging (Albany NY); 2019 Aug; 11(15):5445-5462. PubMed ID: 31377747
[TBL] [Abstract][Full Text] [Related]
20. Impact of aldosterone on osteoinductive signaling and vascular calcification.
Lang F; Ritz E; Alesutan I; Voelkl J
Nephron Physiol; 2014; 128(1-2):40-5. PubMed ID: 25377380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
